The application of sentinel nodes to the management of breast cancer is the most important change in surgical management of breast cancer in decades. This is evidenced by a continuously expanding literature base which now includes more than 4,000 articles.
Sentinel node surgery is now being used worldwide and millions of women have had this procedure performed. As new findings continue to emerge it is important to stay on top of this information and apply best practices. Subscribers to Sentinel Nodes and Breast Cancer will instantly gain a unique and comprehensive overview of the worlds literature.
The Tree of Medicine® is the absolute definitive source on sentinel node and breast cancer, with over 10 years of extensive development invested. Signing up is absolutely free, thanks to the help of our generous sponsors. You'll gain access to a collection of every sentinel node and breast cancer article meticulously organized by our subject experts.
In addition to full access to the app, we provide a free monthly email to update you on recent articles published in sentinel node and breast cancer that have been reviewed by our editors. We find the articles so that you don't have to!
Armando E. Giuliano, MD, is Executive Vice Chair of Surgery for Surgical Oncology, Co-director of the Saul and Joyce Brandman Breast Center -A Project of Women's Guild and Associate Director for Surgical Oncology at the Samuel Oschin Comprehensive Cancer Institute.
Dr. Giuliano is a world renowned expert and pioneer of sentinel nodes and breast cancer. He has made fundamental contributions to the field of sentinel node surgery.
In addition to serving as Chairman of the American College of Surgeons Oncology Group Breast Organ Site Research Committee, Dr. Giuliano served as Chairman of the Breast Fellowship Program Directors Committee for the Society of Surgical Oncology. He is the 2011 President of the International Sentinel Node Society.
Please see: Link
David Krag, M.D., F.A.C.S. is the SD Ireland Professor of Surgical Oncology at the University of Vermont, USA. He is Senior Editor of the Tree of Medicine's Sentinel Nodes and Breast Cancer module. He is a pioneer of and international leader in the area of sentinel node surgery and breast cancer. He is Principle Investigator for the NSABP-B32 trial comparing sentinel node surgery to axillary node resection. He has organized training of hundred’s of surgeons in the methods of sentinel node surgery.
Dalliah M. Black, MD, FACS is an Assistant Professor of Surgical Oncology at the University of Texas MD Anderson Cancer Center in Houston. Dr. Black’s clinical interests include evaluating barriers to medical care in the underserved and disparities in breast cancer outcomes. Dr. Black has a strong interest in patient education and the patient-physician relationship. She has received several awards for her community efforts.
She has also served on the board of directors for the breast cancer support group, The Red Devils, as a medical advisor for Sisters Network, and served on the state of Maryland Breast Cancer Control Commission to improve access and treatment. She is a Fellow of the American College of Surgeons and a member of the American Society of Breast Surgeons and Society of Surgical Oncology.
Dr. Piñero is specialist in General Surgery and Associate Professor of Surgery with special dedication to breast cancer, melanoma and sarcoma. He works in the Department of Surgery at the “Virgen de la Arrixaca” University Hospital in Murcia, Spain. As President of the Ethical Commitee (IRB) he is very interested in clinical trials, and currently he is Director of the Group of Senologic Studies of the Spanish Society of Senology. He is member of the Spanish Association of Surgeons, and author of more than one hundred scientific publications. In 2006, he coordinated the Spanish Consensus Meeting on Sentinel Node Biopsy in Breast Cancer.
Dr. McCready holds The Gattuso Chair in Breast Surgical Oncology at Princess Margaret Hospital and is Head of the Breast Centre at Princess Margaret Hospital in Toronto, Canada. He is principle investigator of the National Surgical Adjuvant Breast and Bowel Project at the Princess Margaret Hospital site and is a member of the Breast Site Executive of the National Institute of Canada Clinical Trials Group.
Dr. McGready has a strong interest in Continuing Professional Development, clinical trials and sentinel node surgery in breast cancer.
Dr. Sato is Director of the Breast Oncology Center and Chair of the Department of Breast Oncology at Tokyo-West Tokushukai Hospital at Sun Yat-sen University in Tokyo Japan. His research in breast cancer sentinel lymph nodes has involved the study of Tin colloids for radioguided resection of the sentinel nodes and the relationship of particle size. He has also studied the use of ultrasound for preoperative evaluation of sentinel nodes. He is very interested in education and is the Director of the residency training program at the Tokyo-West Tokushukai Hospital.
Dr. Imoto is Professor of the Department of Breast Surgery, School of Medicine, Kyorin University, Tokyo, Japan. He has published on sentinel nodes and breast cancer for more than a decade and his research includes evaluation of isolated tumor cells in sentinel nodes, prediction of the status of nonSNs, and the impact of the method of scoring lymph nodes. He is a principle investigator of the Japanese Society for Sentinel Node Navigation Surgery. He has published 80 papers about oncology. Dr. Imoto is developing new methods of minimally invasive surgery of the breast for sentinel node biopsy and radiofrequency ablation. His research is grant-supported by Health, Labour and Welfare Programs and the Foundation for the Promotion of Cancer Research and by the 3rd-Term Comprehensive 10-year Strategy for Cancer Control in Japan.
Dr. Cody is a world leading expert in the area of sentinel nodes and breast cancer. He has had a major impact on the development of this field and is the Principal Investigator of Memorial Sloan Kettering Cancer Center’s Sentinel Lymph Node Biopsy Program. He is currently President of the New York Metropolitan Breast Cancer Group, serves on the Board of Directors of the American Society of Breast Surgeons, and is an Editor of the journal Breast Diseases. He is also on the Editorial Boards of the Journal of Clinical Oncology and Annals of Surgical Oncology. Please see his extensive biography at http://www.mskcc.org/prg/prg/bios/3.cfm.
Dr. Agarwal is Professor of the Department of Endocrine & Breast Surgery, Sanjay
Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. He was
instrumental in starting the first MCI recognized MCh Endocrine & Breast Surgery
program in the country. He has published more than 120 original papers and short
articles. He has been a recipient of the American College of Surgeons International
Guest Scholarship; UICC-ICRETT fellowship; Robert Schumann foundation
scholarship and Nagoya Red-cross scholarship. Dr. Agarwal has served as
Secretary General of Breast Surgery International, executive council member of
the International Society of Surgery. He is one of the founding members of the
Association of Breast Surgeons of India, and is a member of its executive council.
Dr. Ines Buccimazza is Senior Specialist in the Department of Surgery at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. Her work focuses on surgical management of breast cancer. She has been chairperson of the Breast Cancer Forum for KZN (KwaZulu-Natal) for nearly a decade. Her international breast cancer activities are through ISW and Breast Surgery International where she holds leadership positions. Dr. Buccimazza is on the executive committee of the Association of Surgeons of South Africa. She brings an important perspective on issues related to management of breast cancer in developing countries.